Gessel has advised the Polish Stem Cell Bank on the signing of a preliminary contract for the purchase of 100% of shares in Germany's Eticur from InGeneron and another owner.
Gessel reports that “the transaction depends on the fulfillment of certain conditions, including Eticur’s repayment of part of the loans granted by the seller.”
Gessel’s team included Partner Maciej Kozuchowski, Senior Associate Piotr Rysiak, and Associate Anna Haciuk.
Editor's Note: After this article was published Bird & Bird announced that it had advised InGeneron on the deal. The firm's team included Munich-based Partner Stefan Munch and Associate Daniel Gloor.
